Last updated on January 2019

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Brief description of study

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Clinical Study Identifier: NCT03249376

Contact Investigators or Research Sites near you

Start Over

Kimberly Vanover, PhD

Clinical Site
Shreveport, LA United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.